APA (7th ed.) Citation

Brenner, D., Sieverding, K., Kröger, C., Lüningschrör, P., Buck, E., Mungwa, S., . . . Weishaupt, J. H. (2019). Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice. Journal of experimental medicine, 216(2), . https://doi.org/10.1084/jem.20180729

Chicago Style (17th ed.) Citation

Brenner, David, et al. "Heterozygous Tbk1 Loss Has Opposing Effects in Early and Late Stages of ALS in Mice." Journal of Experimental Medicine 216, no. 2 (2019). https://doi.org/10.1084/jem.20180729.

MLA (9th ed.) Citation

Brenner, David, et al. "Heterozygous Tbk1 Loss Has Opposing Effects in Early and Late Stages of ALS in Mice." Journal of Experimental Medicine, vol. 216, no. 2, 2019, https://doi.org/10.1084/jem.20180729.